GlassScriptPhysician profile
Craig A Conti
NPI 1083683502
$990.13
in general payments reported to CMS, 2019-2025
20 companies · $269 in 2025
The $269 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $47.96 · 2021: $152 · 2022: $140 · 2023: $89.96 · 2024: $113 · 2025: $269.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $472.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $472.15 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $197.20 | 2019-2024 | Prostep, Prophecy |
| Kerecis Limited | $153.87 | 2022-2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Smith+Nephew, INC. | $90.52 | 2022-2025 | Grafix Pl, Stravix |
| Arthrex, INC. | $74.90 | 2021 | |
| Coastal Medical Technologies LLC | $55.02 | 2023-2025 | |
| Depuy Synthes Sales INC. | $51.47 | 2023-2025 | Na, Dynaforce, Motoband |
| Wright Medical Technology, INC. | $48.50 | 2019 | |
| Bioventus LLC | $42.92 | 2020-2025 | Exogen Ultrasound Bone Healing System |
| Nevro Corp. | $37.18 | 2022-2024 | Senza |
| Horizon Therapeutics Plc | $35.36 | 2021-2022 | |
| Averitas Pharma INC. | $30.25 | 2024 | Qutenza |
| Merck Sharp & Dohme LLC | $25.49 | 2019 | |
| Djo, LLC | $24.97 | 2024 | Cmf |
| Boston Scientific Corporation | $23.32 | 2021 | |
| Mvp Orthopedics INC | $18.63 | 2022 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $18.39 | 2021 | |
| Angiodynamics, INC. | $17.59 | 2022 | |
| Orthofix Medical, INC. | $16.45 | 2021 | |
| Zimvie INC. | $15.84 | 2023 | |
| Zyla Life Sciences, INC. | $12.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Craig Conti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.